Tonix Pharmaceuticals Holding Corp. The company is headquartered in Chatham, New Jersey. Show more

200 CONNELL DRIVE, BERKELEY HEIGHTS, NJ, UNITED STATES, 07928, Berkeley Heights, NJ, 07928, USA

BIOTECHNOLOGY
HEALTHCARE

Market Cap

234.3M

52 Wk Range

$9.40 - $33.22

Previous Close

$12.45

Open

$12.56

Volume

1,142,619

Day Range

$12.50 - $13.95

Enterprise Value

40.29M

Cash

176.2M

Avg Qtr Burn

-42.24M

Insider Ownership

0.13%

Institutional Own.

56.07%

Qtr Updated

06/30/26


Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date

Approved

Quarterly sales

TNX-102 SL Details
Acute Stress Reaction

Phase 2

Data readout

TNX-1300 Details
Cocaine overdose / intoxication

Phase 2

Data readout

TNX-1900 Details
Bone disorder, Bone health, Autism spectrum disorders

Phase 2

Data readout

TNX-1900 Details
Psychiatric disorder, Binge eating disorder

Phase 2

Data readout

TNX-1900 Details
Social Anxiety Disorder

Phase 2

Data readout

Phase 2

Data readout

TNX-102 SL Details
Alcohol dependence

Phase 2

Update

TNX-102 SL Details
Agitation, Alzheimer's disease

Phase 2

Update

TNX-102 SL Details
Major Depressive Disorder

Phase 2

Update

Phase 2

Update

TNX-102 SL Details
Sleeping disorder, Post-traumatic stress disorder

Phase 2

Update

TNX-2900 Details
Prader-Willi syndrome

Phase 2

Initiation

TNX-4800 Details
Lyme Disease

Phase 2

Initiation

TNX-1500 Details
Kidney transplantation, Graft-versus-host disease , Hematopoietic cell transplantation

Phase 2

Initiation

Phase 1

Initiation

TNX-1700 (TFF2-Albumin Fusion) Details
Gastric And Colorectal Cancer

IND

Submission

TNX-4200 (CD45 Modulator) Details
High Lethality Viral Infections

IND

Submission

TNX-4700 (BTLA Antagonist) Details
Immuno-Oncology Indications

IND

Submission

Failed

Discontinued

TNX-601 Details
Major depressive disorder

Failed

Discontinued